VSee Health (VSEE) said Monday it expanded its telehealth service offering by launching a new specialized program that will integrate GLP-1 prescription medicines within its existing offerings and is designed to address obesity and related health risks.
The GLP-1 initiative will combine telehealth access, prescription drug support and behavioral intervention, with participants set to receive personalized care plans, virtual support calls and access to GLP-1 medicines. The program provides subscriptions at $4.99 a month, VSee said.
Shares of the company were up 26% in recent Monday premarket activity.
Price: 2.0700, Change: +0.43, Percent Change: +26.22
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。